NeoTYPE™ Cancer Profiles are multi-method test panels, custom-designed for a specific tumor type, that identify the genetic changes most significant to therapy decisions, prognosis, and clinical research. Read more.
Specimen Requirements Guide (PDF)
Specimen Hold Options
Concurrent analysis of ZAP-70 by flow cytometry, CLL-related chromosome abnormalities by FISH, and mutations of the IgVH, NOTCH1, and SF3B1 genes by bi-directional sequencing. Results are issued together in a comprehensive report.
Read more about the NeoTYPE™ CLL Prognostic Profile.